poisar

Stocks · News reference

Kiniksa Pharmaceuticals Q2 EPS $0.30 Beats $0.27 Estimate, Sales $243.600M Beat $225.457M Estimate

Jul 28, 2026, 11:31 AMBenzinga Newsdesk

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.27 by 11.11 percent. This is a 30.43 percent increase over earnings of $0.23 per share

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KNSA
Source
benzinga
Observed
Jul 28, 2026, 11:31 AM
Checked
Jul 28, 2026, 11:31 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading